The Leahy Library Filters: All Years20232022202120202019201820172016All TypesPhoenix IssuesInstitute AgendasCourt FilingAmicus PapersAll TagsLife SciencePost Grant OppositionsProsecutionEcouraging InnovationInternationalLitigation Document Type Tags Year 2023 Roundtable Issue #1 – Patent Prosecution Proposals for Reforming “Prep and Pros” for the 21st Century Phoenix Issues Litigation 2023 For “Patent Wars” Alarmists, Time to Make Peace with the Empirical Data Phoenix Issues Prosecution 2023 New Director Reviews: The Latest IPR Guidance From the Patent Office Phoenix Issues Prosecution 2023 Patent System Reforms for Improving Robustness and Reliability Amicus Papers 2023 Request for Comments on USPTO Initiatives To Ensure the Robustness and Reliability of Patent Rights Phoenix Issues Litigation 2023 Restoring Deterrence: The Case for Enhanced Damages in a No-Injunction Patent System Phoenix Issues Litigation 2023 Section 101 Patentable Subject Matter Phoenix Issues Prosecution 2023 What The Latest Case Data Reveals About Stays Pending IPR Phoenix Issues Prosecution 2023 2022 Phoenix Issues A document listing the Phoenix Issues for 2022. Institute Agendas 2022 7 Hot Topics in IP for Pharma AI and Bioinformatics Phoenix Issues Litigation 2022 A Different Ball Game: Depositions at the PTAB and District Court Phoenix Issues 2022 FRAND goes global Phoenix Issues Litigation 2022 How Increased Stays Pending IPR May Affect Venue Choice Phoenix Issues 2022 Naples Roundtable Recommends Suspension of Patent Office Relationships With Aggressor States Amicus Papers International 2022 OpenSky Industries, LLC v. VLSI Technology LLC, IPR2021-01064 (PTAB) and Patent Quality Assurance, LLC v. VLSI Technology LLC, IPR2021-01229 (PTAB) Amicus Papers Post Grant Oppositions 2022 Should the U.S. Congress give Patent Owners the Benefit of a Foreign Jurisdiction’s Determination Regarding Subject-Matter Eligibility? Phoenix Issues 2022 The USPTO Should Give Ukraine Even More Help Amicus Papers International 2022 What would a fresh start look like? Phoenix Issues Life Science 2022 2021 Phoenix Issues A document listing the Phoenix Issues for 2021. Institute Agendas 2021 Antitrust Analysis Involving Intellectual Property and Standards: Implications from Economics Document by Jorge Padilla, Douglas H. Ginsburg, & Koren W. Wong-Ervin on Antitrust Analysis. Phoenix Issues Litigation 2021 Background Materials for Discussion Document containing background materials for discussion on issue VI by George Pappas. Phoenix Issues 2021 Constitutional Confines of Our Patent System and Subject Matter Eligibility: Nine Answers to Ten Questions That Need Addressing Document by Robert A. Armitage on questions about the Patent System and Subject Matter Eligibility. Phoenix Issues Life Science 2021 Federal Circuit Appeals from the PTAB: Summaries of Key 2019 Decisions Document by Sterne Kessler on key 2019 decisions. Phoenix Issues Prosecution 2021 Federal Circuit Sheds New Light on TCL v. Ericsson: U.S. Patent Office, U.S. Dept. of Justice and NIST Issue New Joint Statement on SEP Remedies Document on SEP Remedies as related to TCL v. Ericsson by Kenneth Adamo. Phoenix Issues Litigation 2021 Framework for Analysis of Standard-Essential Patent (SEP) and Fair, Reasonable, and Non-Discriminatory (FRAND) Licensing and Royalty Issues—Stage Two Document from A Project of The Sedona Conference Working Group on Patent Damages and Remedies (WG9) regarding SEP and FRAND. Phoenix Issues Litigation 2021 How to improve IPRs without tossing the baby out with the bath water Document by Russell Slifer on improving IPRs. Phoenix Issues Prosecution 2021 Legislative and Regulatory Proposals to Incentivize Post-Grant Review over Inter Partes Review Document by Andrew S. Baluch on incentivizing post-grant review. Phoenix Issues Prosecution 2021 Legislative Proposal to Improve Inter Partes Reviews for Both Patent Owners and Petitioners Amicus Papers Ecouraging Innovation 2021 OECD Competition Committee Roundtable on “Licensing of IP Rights and Competition Law” Document by Koren Wong-Ervin on key Licensing of IP Rights and Competition Law. Phoenix Issues Litigation 2021 Policy Statement on Remedies for Standards-Essential Patents Subject to Voluntary F/RAND Commitments Document by U.S. Patent & Trademark Office (USPTO), the National Institute of Standards and Technology (NIST), and the U.S. Department of Justice, Antitrust Division (DOJ) on remedies for Standards-Essential Patents subject to voluntary F/RAND commitments. Phoenix Issues Litigation 2021 Policy Workshop on USPTO’s Rulemaking Authority Amicus Papers Prosecution 2021 Request to Designate Certain Board Decisions as Precedential Amicus Papers 2021 Section 101 and Life Sciences: What’s Left to Patent After Myriad, Mayo, And Alice? Document by Warren D. Woessner and Robin A. Chadwick on Section 101 and Life Sciences. Phoenix Issues Life Science 2021 STRONGER (Support Technology & Research for Our Nation’s Growth and Economic Resilience) Patents Act of 2019 Document on STRONGER Patents Act of 2019 by the 116th Congress. Phoenix Issues Prosecution 2021 The PTAB Handbook Fifth Edition Fifth edition handbook on PTAB by William P. Atkins. Phoenix Issues Prosecution 2021 “Excessive Royalty” Prohibitions and the Dangers of Punishing Vigorous Competition and Harming Incentives to Innovate Document on “Excessive Royalty” Prohibitions by Douglas H. Ginsburg, Bruce H. Kobayashi, Koren W. Wong-Ervin, & Joshua D. Wright. Phoenix Issues Litigation 2020 2020 Phoenix Issues A document listing the Phoenix Issues for 2020. Institute Agendas 2020 Access to Relevant Prior Art Postcard by USPTO. Phoenix Issues 2020 AIA’s Failure to Conform the Right to Claim Priority (35 U.S.C. §§ 119 and 120) with Assignee-Filing Authority (35 U.S.C § 118) May Jeopardize Thousands of Patents’ Priority Dates Document on AIA's failure to conform the right to claim priority by Andrew Baluch Phoenix Issues Litigation 2020 Chrimar Systems Inc v. ALE USA INC. Amicus Papers Litigation 2020 Communication from the Commission to the European Parliament, the Council and the European Economic and Social Committee: Setting Out The EU Approach To Standard Essential Patents (Brussels, 29.11.2017) Communication from the Commission to the European Parliament, the Council and the European Economic and Social Committee on setting out the EU approach to Standard Essential Patents. Phoenix Issues Litigation 2020 FTC v. Qualcomm: Part One — Where is Denzel? Blog by David Long. Phoenix Issues Litigation 2020 Global Rate-Setting: A Solution for Standards-Essential Patents? Phoenix Issues Litigation 2020 Guidelines of Guangdong High People’s Court on Adjudicating Cases of Disputes Over Standard-Essential Patents (Trial) Phoenix Issues Litigation 2020 In the Quest to Strengthen and Improve the Patent System: The Imperative for Elevating Patent Examination Integrity Document on elevating Patent Examination Integrity by Robert A. Armitage. Phoenix Issues Litigation 2020 In The Quest To Strengthen The U.S. Patent System: The Imperative For Addressing The “Implicit Exception” Administratively Document by Robert A. Armitage on the imperative for addressing the "Implicit Exception" administratively. Phoenix Issues Prosecution 2020 Issue X: Understanding The Conflict of Positions In the SEP / FRAND Issues – Latest US Views Document on Phoenix Issue X by Ken Adamo. Phoenix Issues Litigation 2020 Key Patent Harmonization Issues Document on patent harmonization issues by SUGHRUE MION, PLLC. Phoenix Issues 2020 Patent Eligibility and Experimental Use: An International Comparison Document by Andrew Baluch, Teresa Summers and Jason Well on patent eligibility and experimental use. Phoenix Issues Prosecution 2020 Phoenix Issue V Document on Phoenix Issue V for 2019 by Paul Cole. Phoenix Issues 2020 Product Hopping and the Limits of Antitrust: The Danger of Micromanaging Innovation Document on product hopping and the limits of antitrust by Douglas H. Ginsburg, Koren W. Wong-Ervin, & Joshua D. Wright. Phoenix Issues Litigation 2020 Proposal to Expedite Joinder in Inter Partes Review Proposal to Expedite Joinder in Inter Partes Review by Andrew S. Baluch and Teresa Stanek Rea. Phoenix Issues 2020 Recommendations Following the FTC’s October 2018 Hearings on IP and Innovation Document on recommendations following the FTC's October 2018 hearings by Koren W. Wong-Ervin & Dr. Georgios Effraimidis. Phoenix Issues Litigation 2020 Section 101: What’s Left To Patent In The Life Sciences After Myriad, Mayo, And Alice? Document on section 101 by Warren D. Woessner and Robin A. Chadwick. Phoenix Issues Prosecution 2020 The More Things Change: Improvement Patents, Drug Modifications, and the FDA Document on changes in patents, drug modifications, and the FDA by Dmitry Karshtedt. Phoenix Issues Litigation 2020 The Sedona Conference Framework for Analysis of StandardEssential Patent (SEP) and Fair, Reasonable, and Non-Discriminatory (FRAND) Licensing and Royalty Issues (Stage One) Document from A Project of The Sedona Conference Working Group on Patent Damages and Remedies (WG9) on SEP and FRAND. Phoenix Issues Litigation 2020 Tying and Bundling Involving Standard-Essential Patents Document on tying and bundling involving standards-essential patents by Koren W. Wong-Ervin, Evan Hicks, & Ariel Slonim. Phoenix Issues Litigation 2020 Understanding the Conflict of Positions on FRAND Phoenix Issues Litigation 2020 “The Impact of Bad Patents on American Businesses” Supplemental Statement of Judge Paul R. Michel (Ret.) Before the Subcommittee on Courts, Intellectual Property, and the Internet, Committee on the Judiciary, United States House of Representatives Phoenix Issues Post Grant Oppositions 2019 2019 Phoenix Issues A document listing the Phoenix Issues for 2019. Institute Agendas 2019 A UK Perspective Phoenix Issues 2019 A Unified Proposal Superseding The “Implicit Exception” To Patent Eligibility Harmonizing The Aba, Ipo, Aipla, And Banbury Conference Initiatives On § 101 Reform Phoenix Issues Prosecution 2019 Boundaries, Extraterritoriality, And Patent Infringement Damages Phoenix Issues Litigation 2019 Delrahim speech shows Trump administration DoJ will no longer favour IP users over owners, says Kappos This article was first published on the IAM daily blog by Globe Business Media Group. To visit IAM please go to www.IAM-media.com. Phoenix Issues Litigation 2019 Director Andrei Iancu’s Act One Phoenix Issues Prosecution 2019 Enhancing Patent Damages Phoenix Issues 2019 Extra-Jurisdictional Remedies Involving Patent Licensing Phoenix Issues Litigation 2019 Federal Circuit Law on Attorneys’ Fees After Octane Fitness Phoenix Issues 2019 GOPRO INC. v. 360HEROS, INC. Amicus Brief Amicus Papers Litigation 2019 Guide to Licensing Negotiations Involving Standard Essential Patents Guide to licensing negotiations involving Standard Essential Patents from the Japan Patent Office. Phoenix Issues 2019 Has the AIA Strengthened the Patent System? Paper Phoenix Issues Post Grant Oppositions 2019 Has the AIA Strengthened the Patent System? Powerpoint Phoenix Issues Post Grant Oppositions 2019 IAM Response to Delrahim Speech This article was first published on the IAM daily blog by Globe Business Media Group. To visit IAM please go to www.IAM-media.com. Phoenix Issues Litigation 2019 Impact of the America Invents Act on US and International Litigation Strategy Phoenix Issues Post Grant Oppositions 2019 Impression Products Inc. V. Lexmark International, Inc. Phoenix Issues 2019 IP insider: The patent follies of antitrust zealots This article was first published on the IAM daily blog by Globe Business Media Group. To visit IAM please go to www.IAM-media.com. Phoenix Issues Litigation 2019 Letter to Chairman Tillis Amicus Papers Ecouraging Innovation 2019 Patent Bar Groups Propose Legislation to Fix Patent Subject Matter Eligibility Problems Phoenix Issues Prosecution 2019 Patent Eligibility and Experimental Use: An International Comparison Amicus Papers International 2019 Patent owners should not fear the Unified Patent Court Phoenix Issues 2019 Patent Strategy in Europe in view of the Unitary Patent System and BREXIT Phoenix Issues 2019 PGR Basics; Pros/Cons Phoenix Issues Post Grant Oppositions 2019 PGR vs. IPR Chart Phoenix Issues Post Grant Oppositions 2019 Post Grant Patent Challenge Procedures Under Fire at The Supreme Court Phoenix Issues 2019 Potential Impact of Oil States vs. Greene’s Energy Group on Final Written Decisions and Parallel Judgments Phoenix Issues Prosecution 2019 Proposal for Best Patent Filing/Prosecution Strategy in Europe in View of UP/UPC/BREXIT – State of Considerations December 5, 2017 Phoenix Issues 2019 Structure of the Unified Patent Court Phoenix Issues 2019 Testimony On International Antitrust Enforcement Phoenix Issues Litigation 2019 The Department of Justice’s Long-Awaited and Much Needed Course-Correction on FRAND-Assured Standard-Essential Patents Competition Policy International, forthcoming November 2017 Phoenix Issues Litigation 2019 The Impact of TC Heartland on Hatch-Waxman and BPCIA Litigation Phoenix Issues 2019 The Role of IP In Economic Growth –Looking Back, Looking Forward Phoenix Issues Post Grant Oppositions 2019 The Willful Infringement Standard: Notes on its Development, Impact, and Future Trends Phoenix Issues 2019 UK and UPC: a test of compatibility Phoenix Issues 2019 Unified Patent Court Procedure Phoenix Issues 2019 Unitary Patent in Europe & Unified Patent Court (UPC): An overview and a comparison to the “classical“ patent system in Europe Phoenix Issues 2019 [29] Riley Survey of Trade Secret Investigations at ITC Phoenix Issues Prosecution 2018 2018 Phoenix Issues A document listing the Phoenix Issues for 2018. Institute Agendas 2018 8 Practical Steps for China to Become an Innovation Led Economy by David J. Kappos and David P. Willard Phoenix Issues Litigation 2018 A Trend Towards Abuse of Discretion Review Phoenix Issues 2018 Additional PGR Slides Phoenix Issues 2018 AIPLA Patent Stats 2017 Mid-Winter Paper Phoenix Issues 2018 At Stanford, Patent Experts Sound Off on Section 101 (Corporate Counsel 12-06-2016) Phoenix Issues Life Science 2018 BASF Corporation v. SNF Holding Company, Et Al. Related to Phoenix Issue IV, 2018 Court Filing 2018 Best Strategies in Europe in View of BREXIT by Heinz Goddar Phoenix Issues 2018 Can We Find a Rational, Principled, Expansive, and Politically Palatable Approach to Statutorily Defining Patent Eligibility by Robert A. Armitage Phoenix Issues Life Science 2018 CBMPGR Grounds Analysis Phoenix Issues 2018 Chapter 15 Phoenix Issues 2018 Chapter Two New Global Patent Landscape by Robert Greene Sterne Phoenix Issues 2018 Creating a Patent System Fostering Only Pro-Patent Sentiments by Robert A. Armitage Phoenix Issues Litigation 2018 DTSA REVIEW FOR INSIDE COUNSEL Phoenix Issues Prosecution 2018 Extra-Jurisdictional Remedies Involving Patent Licensing Phoenix Issues Litigation 2018 HELSINN HEALTHCARE S.A. v. TEVA PHARMACEUTICALS INC. Amicus Brief in Support of Neither Party Amicus Papers Litigation 2018 Hunter Douglas Inc., Et Al. v.Ching Feng Home Fashions Co.,Ltd. Court Filing 2018 Injunction and Damage in Brazilian Patent Infringement by Liliana Roriz and Otto Licks Phoenix Issues 2018 James Pooley, The Myth of the Trade Secret Troll-Why the Defend Trade Secrets Act Improves the Protection of Commercial Information, 23 George Mason LR 1045 (Summer 2016) Phoenix Issues Prosecution 2018 Japanese Perspective by Dr. Shoichi Okuyama Phoenix Issues 2018 JPO Presentation by Yoshinori Kamiya Phoenix Issues 2018 Letter re Department of Industrial Policy and Promotion’s Discussion Paper on Standard Essential Patents and Their Availability on FRAND Terms by David J. Kappos Phoenix Issues Litigation 2018 Mediation- Do Claims for Enhanced Damages and Sanctions Affect Mediation Success by Hon. Faith Hochberg Phoenix Issues 2018 Naples Conf 2016 Recent Developments in Claim Construction_(44711542_2) Phoenix Issues 2018 Pleadings After Form 18 How Has the Rubber Hit the Road by Deborah Fishman, Clara Wang, and Aaron Nathan Phoenix Issues 2018 Pooley treatise excerpt re DTSA Phoenix Issues Prosecution 2018 PROPPANT EXPRESS INVESTMENTS, LLC v. OREN TECHNOLOGIES, LLC Amicus Brief Amicus Papers Litigation 2018 Section 101 USPTO Roundtable Speaking Points Phoenix Issues Life Science 2018 Sedona WG10 Exceptional Case Determination Section (Oct. 2016 publ comm)… Phoenix Issues 2018 Sedona WG10 Patent Lit Best Practices-Heightened Pleading Stnds Ch. (May 2016 publ comm)_05-23-16 Phoenix Issues 2018 Sedona WG10 Patent Lit Best Practices-Intro Ch. (July 2015 ed)_07_21_15 Phoenix Issues 2018 Sedona WG10 Patent Lit Best Practices-Parallel USPTO Proceedings Ch. – Stg 1 (Oct 2016 ed)_10-15-16 Phoenix Issues 2018 Sedona WG10 Patent Lit Best Practices-Sect 101 Motions (Sept. 2016 publ comm)_09-26-16 Phoenix Issues Life Science 2018 Sedona WG10+9 Patent Lit Commentaries – Exec Summary – 11-14-16 ver (links) Phoenix Issues 2018 Seeking Guidance on Willfulness after Halo and Stryker –Look to the Past by Andrew S. Baluch Phoenix Issues 2018 Standard Essential Patents and Market Power Phoenix Issues Litigation 2018 State of the Patent Trial and Appeal Board by Scott Boalick Phoenix Issues 2018 Strategic patent prosecution in Brazil by Licks Attorneys Phoenix Issues 2018 The Impact of Amended Rule 26(b)(1) on Discovery in Patent Litigation by Byron Holz, Louis Tompros and Chaloea Williams Phoenix Issues 2018 The Impact of Brexit on Intellectual Property Phoenix Issues 2018 The Smallest Salable Patent Practicing Unit and Observations on Its Origins, Development, and Future by David J. Kappos and Paul R. Michel Phoenix Issues Litigation 2018 Twilio, Inc. v. Telesign Corporation Court Filing 2018 Weighing the Patent System It is Time to Confront the Bias Against Patent Owners in Patent Reform Legislation by Adam Mossoff Phoenix Issues Litigation 2018 2017 Phoenix Issues A document listing the Phoenix Issues for 2017. Institute Agendas 2017 A New Approach to Superseding Implicit Exceptions to Patent Eligibliity by Robert A. Armitage Phoenix Issues Life Science 2017 Ariosa v. Sequenom – A Path to the Supreme Court by Paul Cole Phoenix Issues Life Science 2017 Chief Justice’s 2015 Year End Report Phoenix Issues 2017 Doctrine of Exhaustion — The Canadian Experience by Hon. Roger T. Hughes Phoenix Issues 2017 Exhaustion in Developing Countries The Case in Brazil by Otto Licks Phoenix Issues 2017 Exhaustion Outline by Prof. Dr. Heinz Goddar Phoenix Issues 2017 Gilead v Merck – Order Denying Motion to Compel (01-13-2016) Phoenix Issues 2017 Lexmark International Patent Exhaustion by Harold C. Wegner Phoenix Issues 2017 Phoenix Issue I Discussion Outline Phoenix Issues Life Science 2017 Phoenix Issue II Discussion Outline Phoenix Issues Life Science 2017 Phoenix Issue III Discussion Outline Phoenix Issues 2017 Phoenix Issue IV Discussion Outline Phoenix Issues 2017 Phoenix Issue V Discussion Outline Phoenix Issues Post Grant Oppositions 2017 Phoenix Issue V PowerPoint Powerpoint Phoenix Issues Post Grant Oppositions 2017 Phoenix Issue VI Discussion Outline Phoenix Issues 2017 Price Differentiation and the Conundrum of Exhaustion Principles by Prof. Dr. Heinz Goddar Phoenix Issues 2017 Proportionality Under New F R Civ P 26(b) Phoenix Issues 2017 Sedona Working Group Commentary Phoenix Issues 2017 The Mossoff-Noonan ’23 Professors‘ Amicus Brief Phoenix Issues Life Science 2017 The Sequinom Patent Eligibility Challenge by Harold C. Wegner Phoenix Issues Life Science 2017 2016 Phoenix Issues A document listing the Phoenix Issues for 2016. Institute Agendas 2016 HELSINN HEALTHCARE S.A. ROCHE PALO ALTO LLC v. TEVA PHARMACEUTICALS USA, INC. Amicus Brief Amicus Papers Litigation 2016 2023-05-02
